Company profile

Aegicare company profile

Aegicare develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and pharmaceutical companies. That provides sample management, bioinformatics analysis, a family map, and information retrieval. Aegicar uses genetic intelligence to diagnose rare diseases and develop drugs. Aegicar Aegicar develops gene intelligence algorithms for patients, medical institutions, scientific research institutions, and innovative pharmaceutical companies based on cutting-edge bioinformatics, medical genetics, high-throughput sequencing technology, functional genomics technology, artificial intelligence, and cloud computing technology to solve rare disease-related information mining, translation, interpretation, clinical decision-making assistance, and drug development.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Founded
2017-01-01

Headquarters

Headquarters
Saxeville, Wisconsin, United States
Postal code
94301
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$7.8M
Last funding
Series A / $4M / 2019-06-14
Last equity funding
Series A / $4M
Investors
4
Lead investors
2
Founders
3

Founders and investors

Founders

Jian MaLv PeitaoYang Li

Lead investors

DHVCVinno Capital

Investors

ASBVDHVCLishen CapitalVinno Capital

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.